Uncategorized
Alimera applies for 10 additional European Union country approvals for Iluvien
Alimera Sciences anticipates a commercial launch of Iluvien in France in 2014 and has applied to the Medicines and Healthcare Products Regulatory Agency for 10 additional European Union country approvals, according to a press release.“Europe offers the possibility of significant growth, and we believe the market opportunity in Europe is at least as large as that in the United States,” Dan Myers, Alimera president and CEO, said in a subsequent conference call.